Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
about
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
description
scientific article published on 28 March 2019
@en
name
Choosing wisely first line imm ...... t to add and what to leave out
@en
type
label
Choosing wisely first line imm ...... t to add and what to leave out
@en
prefLabel
Choosing wisely first line imm ...... t to add and what to leave out
@en
P2093
P50
P1476
Choosing wisely first line imm ...... t to add and what to leave out
@en
P2093
D Signorelli
G Lo Russo
I De Simone
L M Pallavicini
M C Garassino
M Ganzinelli
P356
10.1016/J.CTRV.2019.03.004
P577
2019-03-28T00:00:00Z